E3

Chronic pain may be a cardiovascular warning sign, not just a symptom

Surviving Cancer Is Not the Same as Being Recovered

Diarrhoeal Disease Progress Is Real. The Inequality Is Still Brutal.

Could AI help prevent the next athlete cardiac tragedy? Evidence is moving faster than practice

Eli Lilly’s retatrutide could reset obesity care, but rising demand and grey-market access are testing regulators and health systems

Metabolic health is no longer just a clinic problem. It is a city, climate and equity problem

Can AstraZeneca challenge the obesity market leaders? New GLP-1 data signal growing ambitions beyond oncology

Pancreatic Cancer Finally Gets a RAS Moment

Not All Eye Infections Are Equal: New Evidence Points to a Precision Medicine Approach
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
